Balyasny Asset Management L.P.

Position in AXGN — Axogen, Inc.

CIK 1218710 Chicago, IL

Position in AXGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,709,072

-$24,305,423 QoQ

Shares Held

253,498

-76.7% QoQ

Ownership

0.472%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#52

of 250 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $729,959,673 across 38 Medical Devices names. AXGN ranks #8 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PEN	Penumbra Inc	1,090,163	$344,218,967
2	MDT	Medtronic plc	986,367	$77,163,489
3	GKOS	GLAUKOS Corp	491,636	$68,711,047
4	ABT	Abbott Laboratories	740,808	$67,220,917
5	EW	Edwards Lifesciences Corp	456,202	$41,268,032
6			739,829	$18,406,945
7	BBNX	Beta Bionics, Inc.	855,682	$13,408,536
8	AXGN	Axogen, Inc. This page	253,498	$11,709,072

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,709,072	253,498	-76.7%	Shares	Sole	2026-08-14
2026-03-31	$36,014,495	1,087,066	+28.3%	Shares	Sole	2026-05-15
2025-12-31	$27,737,169	847,454	-38.6%	Shares	Sole	2026-02-17
2025-09-30	$24,612,813	1,379,642	-28.6%	Shares	Sole	2025-11-14
2025-06-30	$20,953,064	1,931,158	+183.9%	Shares	Sole	2025-08-14
2025-03-31	$12,583,515	680,190	+126.8%	Shares	Sole	2025-05-15
2024-12-31	$4,943,044	299,942	+1241.7%	Shares	Sole	2025-02-14
2023-06-30	$204,110	22,356	-84.0%	Shares	Sole	2023-08-14
2022-03-31	$1,110,424	139,852	-54.8%	Shares	Sole	2022-05-16
2021-12-31	$2,897,456	309,227	+53.1%	Shares	Sole	2022-02-14
2021-09-30	$3,191,173	201,973	-43.1%	Shares	Sole	2021-12-01
2021-06-30	$7,671,787	355,011	+42.4%	Shares	Sole	2021-08-16
2021-03-31	$5,049,825	249,251	+148.0%	Shares	Sole	2021-05-17
2020-12-31	$1,798,735	100,488	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.